Sanofi Canada focuses in on cancer research

Sanofi Canada President and CEO visits BC's Genetic Pathology Evaluation Centre 

Hugh O'Neill, Sanofi Canada's President and CEO (standing) and Dr. Torsten Nielsen, Co-Director of the Genetic …

MONTREAL , Feb. 1, 2012 /CNW Telbec/ - Hugh O'Neill, Sanofi Canada's President and CEO (standing) and Dr. Torsten Nielsen ,Co-Director of the Genetic Pathology Evaluation Centre in Vancouver , BC, discuss the latest advances in microarray technology. Sanofi Canada has a ten-year research collaboration with the Centre, supporting their mission to improve cancer diagnosis, assessment and treatment.

Image with caption: "Hugh O'Neill, Sanofi Canada's President and CEO (standing) and Dr. Torsten Nielsen, Co-Director of the Genetic Pathology Evaluation Centre in Vancouver, BC, discuss the latest advances in microarray technology. Sanofi Canada has a ten-year research collaboration with the Centre, supporting their mission to improve cancer diagnosis, assessment and treatment. (CNW Group/Sanofi Canada)". Image available at: http://photos.newswire.ca/images/download/20120201_C8511_PHOTO_EN_9497.jpg

Read more here:
Sanofi Canada focuses in on cancer research

Related Posts

Comments are closed.